Arboleya L, Brana I, Pardo E, Loredo M, Queiro R
J Clin Med. 2023; 12(7).
PMID: 37048797
PMC: 10094844.
DOI: 10.3390/jcm12072714.
de Beur S, Minisola S, Xia W, Abrahamsen B, Body J, Brandi M
J Intern Med. 2022; 293(3):309-328.
PMID: 36511653
PMC: 10108006.
DOI: 10.1111/joim.13593.
Bosman A, Palermo A, Vanderhulst J, de Beur S, Fukumoto S, Minisola S
Calcif Tissue Int. 2022; 111(4):367-379.
PMID: 35857061
PMC: 9474374.
DOI: 10.1007/s00223-022-01005-8.
Rajeswarie R, Lakshmikantha A, Kannan S, Pillai V, Prasad K
Indian J Surg Oncol. 2022; 12(Suppl 2):338-342.
PMID: 35035166
PMC: 8716746.
DOI: 10.1007/s13193-021-01321-9.
Hawley S, Shaw N, Delmestri A, Prieto-Alhambra D, Cooper C, Pinedo-Villanueva R
J Clin Endocrinol Metab. 2019; 105(3).
PMID: 31730177
PMC: 7025948.
DOI: 10.1210/clinem/dgz203.
Tumor-induced osteomalacia.
Yin Z, Du J, Yu F, Xia W
Osteoporos Sarcopenia. 2019; 4(4):119-127.
PMID: 30775554
PMC: 6372818.
DOI: 10.1016/j.afos.2018.12.001.
Phosphaturic mesenchymal tumors: what an endocrinologist should know.
Boland J, Tebben P, Folpe A
J Endocrinol Invest. 2018; 41(10):1173-1184.
PMID: 29446010
DOI: 10.1007/s40618-018-0849-5.
Dietary Phosphorus Intake and the Kidney.
Chang A, Anderson C
Annu Rev Nutr. 2017; 37:321-346.
PMID: 28613982
PMC: 5686387.
DOI: 10.1146/annurev-nutr-071816-064607.
Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: A case report and review of the literature.
Abate E, Bernet V, Cortese C, Garner H
Bone Rep. 2017; 5:81-85.
PMID: 28326350
PMC: 4926825.
DOI: 10.1016/j.bonr.2015.11.004.
Hyperphosphatemia Management in Patients with Chronic Kidney Disease.
Shaman A, Kowalski S
Saudi Pharm J. 2016; 24(4):494-505.
PMID: 27330380
PMC: 4908098.
DOI: 10.1016/j.jsps.2015.01.009.
Tumor-Induced Osteomalacia.
Kumar R, Folpe A, Mullan B
Transl Endocrinol Metab. 2015; 7(3).
PMID: 26478788
PMC: 4605441.
The PTH-Vitamin D-FGF23 axis.
Blau J, Collins M
Rev Endocr Metab Disord. 2015; 16(2):165-74.
PMID: 26296372
DOI: 10.1007/s11154-015-9318-z.
FGF23 and Phosphate Wasting Disorders.
Huang X, Jiang Y, Xia W
Bone Res. 2015; 1(2):120-32.
PMID: 26273497
PMC: 4472102.
DOI: 10.4248/BR201302002.
Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
Gattineni J, Alphonse P, Zhang Q, Mathews N, Bates C, Baum M
Am J Physiol Renal Physiol. 2013; 306(3):F351-8.
PMID: 24259513
PMC: 3920047.
DOI: 10.1152/ajprenal.00232.2013.
Bone scintigraphic patterns in patients of tumor induced osteomalacia.
Sood A, Agarwal K, Shukla J, Goel R, Dhir V, Bhattacharya A
Indian J Nucl Med. 2013; 28(3):173-5.
PMID: 24250028
PMC: 3822419.
DOI: 10.4103/0972-3919.119541.
Renal phosphate handling: Physiology.
Prasad N, Bhadauria D
Indian J Endocrinol Metab. 2013; 17(4):620-7.
PMID: 23961477
PMC: 3743361.
DOI: 10.4103/2230-8210.113752.
Rickets: Part II.
Shore R, Chesney R
Pediatr Radiol. 2012; 43(2):152-72.
PMID: 23179485
DOI: 10.1007/s00247-012-2536-6.
Fibroblast growth factor 23: state of the field and future directions.
Bhattacharyya N, Chong W, Gafni R, Collins M
Trends Endocrinol Metab. 2012; 23(12):610-8.
PMID: 22921867
PMC: 3502714.
DOI: 10.1016/j.tem.2012.07.002.
FGF-23 levels in patients with AKI and risk of adverse outcomes.
Leaf D, Wolf M, Waikar S, Chase H, Christov M, Cremers S
Clin J Am Soc Nephrol. 2012; 7(8):1217-23.
PMID: 22700885
PMC: 3408118.
DOI: 10.2215/CJN.00550112.
Genetic disorders of phosphate regulation.
Gattineni J, Baum M
Pediatr Nephrol. 2012; 27(9):1477-87.
PMID: 22350303
PMC: 3407352.
DOI: 10.1007/s00467-012-2103-2.
